Form D · Pharmaceuticals
Fidelis Animal Health Inc.
North Brunswick, NJ · CIK 0001869472
Offering snapshot reported Feb 28, 2024 · SEC filing
- Reported sold
- $1M Offering amount: $2M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 16, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 28, 2024 | Initial | $1,000,017 | No comparison | 10 | SEC filing |
| Jul 21, 2021 | Initial | $5,129,692 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506247
Source: Form D, filed Feb 28, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cynthia Davis | Executive |
| Steven Leary | Executive |
| Barry Levinson | Director, Executive, Promoter |
| Andrew Midler | Director |
| Eric Schreiber | Executive |
| Dennis Steadman | Director |
| Kenneth Sylvester | Executive |
| Michael Wells | Director, Executive, Promoter |
| Susan Witham | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
685 Us Highway One, Suite 265
North Brunswick, NJ, 08902
North Brunswick, NJ, 08902